Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10Rectal Neoplasms 3Stomach Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Colonic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Margins of Excision 1Colorectal Cancer Metastatic 1Carcinoma, Neuroendocrine 1

Interventions

aflibercept 3Irinotecan 2Bevacizumab 2XELOX 1Vemurafenib 1Panitumumab 1Leucovorin 1IFL protocol 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Cancer Metastatic × IFL protocol × Clear all
NCT01571284 2018-04-17

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Sanofi

Phase 3 Completed
781 enrolled 28 charts
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡